Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1245.50
-24.30 (-1.91%)
< Home < Back

Dr Reddy's gets nod for anti-platelet drug in China

Date: 26-04-2019

Dr. Reddy's Laboratories has received approval for anti-platelet drug Clopidogrel in China. The company believes that the sales from this product will not be material in the current financial year (FY20).

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.